464280 Stock Chart & Stats
₩5360.00
-₩100.00(-1.83%)
―
--
Day’s Range― - ―
52-Week Range₩5,220.00 - ₩11,650.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)18.70K
Market Cap
₩28.35B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)5.6
Beta0.38
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,530,000
10 Day Avg. Volume19,270
30 Day Avg. Volume18,696
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,462,555.07
Revenue Forecast (FY)₩10.00T>
464280 FAQ
What was TDSPharm Co., Ltd.’s price range in the past 12 months?
TDSPharm Co., Ltd. lowest stock price was ₩5220.00 and its highest was ₩11650.00 in the past 12 months.
What is TDSPharm Co., Ltd.’s market cap?
TDSPharm Co., Ltd.’s market cap is ₩28.35B.
When is TDSPharm Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were TDSPharm Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is TDSPharm Co., Ltd. overvalued?
According to Wall Street analysts TDSPharm Co., Ltd.’s price is currently Undervalued.
Does TDSPharm Co., Ltd. pay dividends?
TDSPharm Co., Ltd. does not currently pay dividends.
What is TDSPharm Co., Ltd.’s EPS estimate?
TDSPharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TDSPharm Co., Ltd. have?
TDSPharm Co., Ltd. has 5,530,000 shares outstanding.
What happened to TDSPharm Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of TDSPharm Co., Ltd.?
Currently, no hedge funds are holding shares in KR:464280
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cellid Co., Ltd.
―
Pharmsville Co., Ltd.
―
Precision Biosensor, Inc.
―
NGeneBio Co., Ltd.
―
Genesystem Co., Ltd.
―